Citation Information :
Niyas VK, Thomas S, Muralidharan R, Thomas A, Wilson AP, Mahendran B. MIS-C/A/V: There is More to It than Meets the Eye!. Indian J Crit Care Med 2022; 26 (4):534-534.
Iyengar KP, Nune A, Ish P, Botchu R, Shashidhara MK, Jain VK. Multisystem inflammatory syndrome after SARS-CoV-2 vaccination (MIS-V), to interpret with caution. Postgrad Med J 2021:postgradmedj-2021-140869. DOI: 10.1136/postgradmedj-2021-140869.
Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2021;39(22):3037–3049. DOI: 10.1016/j.vaccine.2021.01.054.
Arjun R, Niyas VKM, Thomas SM, Raman M, Thomas A, Aloysius W, et al. Multisystem inflammatory syndrome in adults and adolescents (MIS-A) associated with COVID-19 infection: a single-center experience. Indian J Crit Care Med 2022;26(1):145–148. DOI: 10.5005/jp-journals-10071-24066.
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS–CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol 2020;72(11):1791–1805. DOI: 10.1002/art.41454.